Salmeterol and Fluticasone

DRUG5 trials

Sponsors

Sanofi-Aventis Research & Development, GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic ObstructiveRespiratory DisordersRespiratory tract diseases - Wheezing

Phase 3

A randomized, double-blind, placebo-controlled, parallel group study to assess the efficacy and long-term safety of dupilumab in children 2 to <6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze

RecruitingCTIS2023-504331-41-00

Sanofi-Aventis Research & DevelopmentAsthma, Respiratory tract diseases - Wheezing

Start: 2024-08-02Target: 69Updated: 2025-07-17

Unknown Phase

Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric)

CompletedNCT01332422

GlaxoSmithKlineAsthma

Start: 2009-11-30End: 2012-11-30Updated: 2014-07-08

Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

CompletedNCT01332409

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2009-08-31End: 2013-01-31Updated: 2013-06-10

Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

CompletedNCT01395849

GlaxoSmithKlineRespiratory Disorders

Start: 2007-10-31End: 2011-03-31Updated: 2017-05-16

Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

CompletedNCT01395862

GlaxoSmithKlineRespiratory Disorders

Start: 2007-11-30End: 2012-09-30Updated: 2013-08-21